Variant report
Variant | nsv603734 |
---|---|
Chromosome Location | chr6:74709561-74714172 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184736591 | chr6:74710005-74710006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564843305 | chr6:74710008-74710009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369835960 | chr6:74710081-74710082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9360721 | chr6:74710083-74710084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372895936 | chr6:74710107-74710108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112185571 | chr6:74710111-74710112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544123837 | chr6:74710148-74710149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546662656 | chr6:74710176-74710177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12213134 | chr6:74710185-74710186 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs9352046 | chr6:74710299-74710300 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs548329973 | chr6:74710320-74710321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147516950 | chr6:74710345-74710346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs527293557 | chr6:74710351-74710352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552193249 | chr6:74710496-74710497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571210006 | chr6:74710504-74710505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538510615 | chr6:74710518-74710519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs367630180 | chr6:74710548-74710549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140397875 | chr6:74710568-74710569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556757535 | chr6:74710570-74710571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114567783 | chr6:74710571-74710572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535644593 | chr6:74710588-74710589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553851497 | chr6:74710590-74710591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs72953254 | chr6:74710618-74710619 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs7747608 | chr6:74710654-74710655 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs557724812 | chr6:74710681-74710682 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576009216 | chr6:74710701-74710702 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577088835 | chr6:74710702-74710703 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544513142 | chr6:74710719-74710720 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562615303 | chr6:74710747-74710748 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373120225 | chr6:74710762-74710763 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574581477 | chr6:74710763-74710764 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554451907 | chr6:74710788-74710789 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144420110 | chr6:74710856-74710857 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12207763 | chr6:74710860-74710861 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs541819132 | chr6:74710880-74710881 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527379995 | chr6:74710918-74710919 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545602434 | chr6:74710927-74710928 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142662787 | chr6:74710943-74710944 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187547294 | chr6:74710953-74710954 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531200952 | chr6:74710966-74710967 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs373195255 | chr6:74711002-74711003 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146521884 | chr6:74711004-74711005 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs115977130 | chr6:74711013-74711014 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529496271 | chr6:74711067-74711068 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559365767 | chr6:74711076-74711077 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs149218096 | chr6:74711090-74711091 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565880767 | chr6:74711117-74711118 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376282214 | chr6:74711127-74711128 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs35376964 | chr6:74711136-74711137 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557798228 | chr6:74711159-74711160 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ovarian cancer | 17437010 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:74710000-74710600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr6:74710400-74711000 | Enhancers | NHDF-Ad | bronchial |
3 | chr6:74710600-74710800 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr6:74710600-74710800 | Enhancers | Esophagus | oesophagus |
5 | chr6:74710600-74711000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr6:74710600-74711600 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr6:74710800-74711200 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |